Mario Ollero Selected Research

glycine hydrazide

4/2010

Cystic fibrosis transmembrane regulator inhibitors CFTR(inh)-172 and GlyH-101 target mitochondrial functions, independently of chloride channel inhibition.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mario Ollero Research Topics

Disease

19	Cystic Fibrosis (Mucoviscidosis) 07/2016 - 02/2004
5	Proteinuria 04/2021 - 03/2013
4	Nephrotic Syndrome (Syndrome, Nephrotic) 04/2021 - 03/2013
4	Inflammation (Inflammations) 06/2012 - 10/2009
3	Neoplasms (Cancer) 04/2021 - 09/2015
1	Hypertension (High Blood Pressure) 04/2021
1	Necrosis 11/2020
1	Lupus Nephritis 08/2019
1	Lipoid Nephrosis (Glomerulonephritis, Minimal Change) 01/2018
1	Denys-Drash Syndrome 12/2016
1	Wilms Tumor (Wilm's Tumor) 12/2016
1	Frasier Syndrome 12/2016
1	Cystinuria 01/2015
1	Inborn Genetic Diseases (Disease, Hereditary) 01/2015
1	Kidney Calculi (Kidney Stone) 01/2015
1	Bacterial Infections (Bacterial Infection) 07/2014
1	Infections 07/2014
1	Membranous Glomerulonephritis (Membranous Nephropathy) 03/2013
1	Mitochondrial Diseases (Mitochondrial Disease) 07/2011
1	Persistent Infection 05/2011
1	Disease Progression 01/2011
1	Intestinal Obstruction (Obstruction, Intestinal) 10/2010
1	Diarrhea 04/2010
1	Polycystic Kidney Diseases (Polycystic Kidney Disease) 04/2010
1	Liver Diseases (Liver Disease) 11/2007
1	Chronic Pancreatitis 11/2005
1	Fibrosis (Cirrhosis) 03/2005
1	Liver Failure 03/2005
1	Non-alcoholic Fatty Liver Disease 03/2005
1	Insulin Resistance 08/2004
1	Exocrine Pancreatic Insufficiency 02/2004
1	Respiratory Tract Infections (Respiratory Tract Infection) 02/2004
1	Inflammatory Bowel Disease 9 02/2004
1	Asthma (Bronchial Asthma) 02/2004
1	Infertility (Sterility) 08/2002

Drug/Important Bio-Agent (IBA)

8	Proteins (Proteins, Gene)FDA Link 04/2021 - 11/2005
7	Cystic Fibrosis Transmembrane Conductance Regulator (Protein, CFTR)IBA 06/2012 - 08/2004
6	LipidsIBA 04/2019 - 08/2004
5	Fatty Acids (Saturated Fatty Acids)IBA 10/2010 - 02/2004
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2021 - 09/2015
2	Antigen-Antibody Complex (Immune Complex)IBA 08/2019 - 03/2013
2	ChromatinIBA 12/2016 - 08/2002
2	LigandsIBA 07/2016 - 09/2015
2	Chloride Channels (Chloride Channel)IBA 07/2016 - 04/2010
2	NucleotidesIBA 07/2016 - 10/2013
2	IonsIBA 07/2014 - 01/2008
2	EstersIBA 07/2011 - 11/2005
2	Docosahexaenoic AcidsIBA 11/2007 - 02/2004
2	Arachidonic Acid (Vitamin F)IBA 11/2007 - 02/2004
2	PPAR gammaIBA 08/2004 - 08/2004
1	Biological ProductsIBA 04/2021
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 04/2021
1	ElectrolytesIBA 04/2021
1	Serum AlbuminIBA 01/2021
1	AlbuminsIBA 01/2021
1	Small Interfering RNA (siRNA)IBA 01/2021
1	LipopolysaccharidesIBA 01/2021
1	Tyrosine Kinase InhibitorsIBA 11/2020
1	Calcineurin InhibitorsIBA 01/2018
1	Mycophenolic Acid (Cellcept)FDA LinkGeneric 01/2018
1	SteroidsIBA 01/2018
1	Rituximab (Mabthera)FDA Link 01/2018
1	WT1 ProteinsIBA 12/2016
1	Cyclic AMP (AMP, Cyclic)IBA 07/2016
1	Phospholipases A2 (Phospholipase A2)IBA 07/2016
1	Cystine (L-Cystine)IBA 01/2015
1	cholesteryl sulfateIBA 07/2014
1	integrin-linked kinaseIBA 03/2013
1	Low Density Lipoprotein Receptor-Related Protein-2IBA 03/2013
1	Death-Associated Protein KinasesIBA 03/2013
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 03/2013
1	AntioxidantsIBA 07/2011
1	Interleukin-8 (Interleukin 8)IBA 07/2011
1	IsotopesIBA 01/2011
1	Fish OilsIBA 10/2010
1	N- (2- naphthalenyl)- ((3,5- dibromo- 2,4- dihydroxyphenyl)methylene)glycine hydrazideIBA 04/2010
1	glycine hydrazideIBA 04/2010
1	3- ((3- trifluoromethyl)phenyl)- 5- ((3- carboxyphenyl)methylene)- 2- thioxo- 4- thiazolidinoneIBA 04/2010
1	Phospholipids (Phosphatides)FDA LinkGeneric 11/2009
1	EicosanoidsIBA 10/2009
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2009
1	Bicarbonates (Hydrogen Carbonate)IBA 01/2008
1	ChloridesIBA 01/2008
1	AnionsIBA 01/2008
1	Eicosapentaenoic AcidIBA 11/2007
1	Linoleic Acid (Linoleate)IBA 11/2007
1	alpha-Linolenic Acid (Linolenic Acid)IBA 11/2007
1	Ethanol (Ethyl Alcohol)IBA 11/2005
1	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 03/2005
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 08/2004

Therapy/Procedure

3	Therapeutics 11/2020 - 07/2006
1	Intravenous Injections 01/2021
1	Total Parenteral Nutrition 03/2005